Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS* Study
Anne Vincent‐Salomon(Université Paris Sciences et Lettres), V Le Doussal(Hôpital René Huguenin)
Cited by 121
Related Papers
MSC-Regulated MicroRNAs Converge on the Transcription Factor FOXP2 and Promote Breast Cancer Metastasis
|Cell stem cell|2014|178
Pentraxin-3 is a PI3K signaling target that promotes stem cell–like traits in basal-like breast cancers
|Science Signaling|2017|52
Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer
|Cell Reports|2016|45
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp
|Nature Communications|2024|30